相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
M. H. Schiff et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study
M Hakoda et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
BA van de Putte et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Assessing the value of antipsychotics for treating schizophrenia - The importance of evaluating and interpreting the clinical significance of individual service costs
SL Tunis et al.
PHARMACOECONOMICS (2004)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)
分享论文
